Millennium Names Dunsire CEO: Novartis Exec Brings Oncology Experience To Post
This article was originally published in The Pink Sheet Daily
Executive Summary
Deborah Dunsire succeeds Millennium founder Mark Levin, who is leaving to pursue other interests. At Novartis, Dunsire oversaw 10 oncology product launches, including Gleevec and Zometa. She plans to build on Millennium's expertise in oncology, immunology and cardiovascular areas.